467 related articles for article (PubMed ID: 24444396)
21. Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment.
Rodilla E; Pascual JM; Costa JA; Martin J; Gonzalez C; Redon J
J Hypertens; 2013 Aug; 31(8):1683-91. PubMed ID: 23835910
[TBL] [Abstract][Full Text] [Related]
22. Regression of left ventricular hypertrophy with moexipril, an angiotensin-converting enzyme inhibitor, in hypertensive patients.
Sayegh F; Topouchian J; Hlawaty M; Olzewska M; Asmar R
Am J Ther; 2005; 12(1):3-8. PubMed ID: 15662286
[TBL] [Abstract][Full Text] [Related]
23. Clinical determinants of increased left ventricular mass on echocardiogram in medically treated Afro-Caribbean hypertensive patients.
Martin TC; Bhaskar YG; Umesh KV
West Indian Med J; 2008 Sep; 57(4):337-41. PubMed ID: 19566012
[TBL] [Abstract][Full Text] [Related]
24. [Left ventricular hypertrophy in hypertensive African blacks: echocardiographic study of 452 patients].
Niakara A; Ouédraogo N; Nébié LV; Samadoulougou AK; Kaboré NJ; Ouandaogo BJ
Ann Cardiol Angeiol (Paris); 2001 Jun; 50(4):197-201. PubMed ID: 12555592
[TBL] [Abstract][Full Text] [Related]
25. Clinical correlates of left ventricular hypertrophy in black patients with arterial hypertension.
Lepira FB; Kayembe PK; M'buyamba-Kabangu JR; Nseka MN
Cardiovasc J S Afr; 2006; 17(1):7-11. PubMed ID: 16547554
[TBL] [Abstract][Full Text] [Related]
26. Achieving a Systolic Blood Pressure Below 130 mmHg Reduces the Incidence of Cardiovascular Events in Hypertensive Patients with Echocardiographic Left Ventricular Hypertrophy.
Lembo M; Trimarco V; Izzo R; Manzi MV; Rozza F; Gallo P; Morisco C; Bardi L; Esposito G; Forzano I; Santulli G; Trimarco B
J Pharmacol Exp Ther; 2024 Jun; 390(1):4-10. PubMed ID: 38135511
[No Abstract] [Full Text] [Related]
27. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
[TBL] [Abstract][Full Text] [Related]
28. Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy.
Seeman T; Gilík J; Vondrák K; Simková E; Flögelová H; Hladíková M; Janda J
Am J Hypertens; 2007 Sep; 20(9):990-6. PubMed ID: 17765141
[TBL] [Abstract][Full Text] [Related]
29. Association between insulin resistance and left ventricular hypertrophy in asymptomatic, Black, sub-Saharan African, hypertensive patients: a case-control study.
Kianu Phanzu B; Nkodila Natuhoyila A; Kintoki Vita E; M'Buyamba Kabangu JR; Longo-Mbenza B
BMC Cardiovasc Disord; 2021 Jan; 21(1):1. PubMed ID: 33388039
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of left ventricular hypertrophy associated with type-2 diabetes in Shiraz, Iran: a cross-sectional study.
Parsa N; Moheb M; Zibaeenezhad MJ; Karimi-Akhormeh A; Trevisan M; Wallin L; Zaheri PM; Sayadi M; Razeghian-Jahromi I; Moaref A
BMC Cardiovasc Disord; 2023 Feb; 23(1):88. PubMed ID: 36792995
[TBL] [Abstract][Full Text] [Related]
31. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
[TBL] [Abstract][Full Text] [Related]
33. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
34. Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.
Verdecchia P; Sleight P; Mancia G; Fagard R; Trimarco B; Schmieder RE; Kim JH; Jennings G; Jansky P; Chen JH; Liu L; Gao P; Probstfield J; Teo K; Yusuf S;
Circulation; 2009 Oct; 120(14):1380-9. PubMed ID: 19770395
[TBL] [Abstract][Full Text] [Related]
35. Prevalence, types and factors associated with echocardiographic abnormalities among newly diagnosed diabetic patients at Mulago Hospital.
Muddu M; Mutebi E; Mondo C
Afr Health Sci; 2016 Mar; 16(1):183-93. PubMed ID: 27358631
[TBL] [Abstract][Full Text] [Related]
36. Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension.
Assadi F
Pediatr Cardiol; 2007; 28(1):27-33. PubMed ID: 17308944
[TBL] [Abstract][Full Text] [Related]
37. [Left ventricular hypertrophy in black African subjects with artery hypertension: Results of a cross-sectional survey conducted in semi-rural area in Senegal].
Mbaye A; Dodo B; Ngaïde AA; Sy NF; Babaka K; Mingou JS; Faye M; Niang K; Sarr SA; Dioum M; Bodian M; Ndiaye MB; Kane AD; Ndour-Mbaye M; Diao M; Diack B; Kane M; Diagne-Sow D; Thiaw I; Kane A
Ann Cardiol Angeiol (Paris); 2017 Sep; 66(4):210-216. PubMed ID: 28554700
[TBL] [Abstract][Full Text] [Related]
38. Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients: The Campania Salute Network.
Izzo R; Losi MA; Stabile E; Lönnebakken MT; Canciello G; Esposito G; Barbato E; De Luca N; Trimarco B; de Simone G
Hypertension; 2017 Jan; 69(1):136-142. PubMed ID: 27895192
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women.
Salvetti G; Pucci A; Fierabracci P; Ceccarini G; Palagi C; Delle Donne MG; Di Bello V; Piaggi P; Vitti P; Salvetti A; Pinchera A; Santini F
High Blood Press Cardiovasc Prev; 2012 Mar; 19(1):33-9. PubMed ID: 22670585
[TBL] [Abstract][Full Text] [Related]
40. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
Ecder T; Edelstein CL; Chapman AB; Johnson AM; Tison L; Gill EA; Brosnahan GM; Schrier RW
Nephrol Dial Transplant; 1999 May; 14(5):1113-6. PubMed ID: 10344347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
